Stelar and HTS-110 formalize international partnership
Mercoledì 05 Giugno 2013 10:11
PDF Stampa E-mail
Stelar S.r.l. (bioPmed member), based in Italy, and HTS-110 Ltd, based in New Zealand, both leading-class companies in magnetic resonance technology, announced at the recent European Molecular Imaging Meeting (EMIM) 2013 in Turin, their collaboration for development of exciting new Nuclear Magnetic Resonance (NMR) products.
This will bring together their complementary technologies to provide an innovative product to enhance the research capabilities of the scientific community and open new exciting application areas.
Download the press release >>

Read more http://feedproxy.google.com/~r/biopmed-news/~3/trKCSlFe9b8/index.php